Kowin Investments Inc is categorized under Commercial Medical Research in Montebello, CA and active since 1996.
Kowin Investments Inc was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5312100 by the NAICS.
If you are seeking more information, feel free to contact Pui Yuk, Manager at the company’s single location by writing to 830 North Wilcox Avenue, Montebello, California CA 90640 or by phoning (323) 721-5500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kowin Investments Inc |
| Contact Person: | Pui Yuk, Manager |
| Address: | 830 North Wilcox Avenue, Montebello, California 90640 |
| Phone Number: | (323) 721-5500 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5312100 |
| Share This Business: |
Kowin Investments Inc was started in 1996 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5312100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Pui Yuk, Manager for inquiries that concern Kowin Investments Inc by calling the company number (323) 721-5500, as your correspondence is most welcome. Additionally, the physical location of the single location of Kowin Investments Inc can be found at the coordinates 34.027407,-118.123971 as well as the street address 830 North Wilcox Avenue in Montebello, California 90640.
For its online presence, you may visit Kowin Investments Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.